Idea principal
In 494 people with mild to moderate dementia, a four-month exercise programme did not slow cognitive impairment: at 12 months the ADAS-cog score was 25.2 with exercise versus 23.8 with usual care (adjusted difference -1.4, 95% CI -2.6 to -0.2, P=0.03). The difference pointed toward more impairment with exercise, but it was small and of uncertain clinical meaning.
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Exercise is often suggested for brain health, but it was unclear whether a moderate to high intensity aerobic and strength programme could slow cognitive impairment or improve other outcomes in people who already have dementia. The authors tested this in a large trial.
Población y método
Multicentre, pragmatic, investigator-masked randomised controlled trial in 15 English regions, run through National Health Service primary care, community and memory services, dementia research registers and voluntary sector providers. 494 people with dementia were allocated 2:1: 329 to an aerobic and strength exercise programme and 165 to usual care. The exercise arm had four months of supervised exercise and support for ongoing activity in community gyms and NHS premises. The primary outcome was ADAS-cog score (Alzheimer's disease assessment scale-cognitive subscale) at 12 months. Secondary outcomes included activities of daily living, neuropsychiatric symptoms, quality of life, and carer quality of life and burden. The trial is registered as ISRCTN10416500.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1At 12 months the mean ADAS-cog score had increased to 25.2 (SD 12.3) in the exercise arm and 23.8 (SD 10.4) in usual care. The adjusted between-group difference was -1.4 (95% CI -2.6 to -0.2, P=0.03), which indicates slightly greater cognitive impairment in the exercise group; the authors call its clinical relevance uncertain.
- 2No differences were found in secondary outcomes, nor in preplanned subgroups by dementia type, severity of cognitive impairment, sex and mobility.
- 3Compliance was good: over 65% of participants (214/329) attended more than three quarters of scheduled sessions.
- 4Six minute walking distance improved over six weeks, with a mean change of 18.1 m (95% CI 11.6 m to 24.6 m).
Límites e incertidumbre
- 1Participants and trainers knew who was exercising, and only the assessors were masked, which can influence some outcomes.
- 2The programme lasted four months while the main outcome was measured at 12 months, so effects of longer or different exercise are not tested.
- 3Fitness was measured only in the exercise arm, so the walking improvement has no comparison group.
- 4This reading is based on the abstract only.
Relevancia práctica
For people with mild to moderate dementia, this programme improved fitness but did not slow cognitive decline or improve other measured outcomes. That does not mean activity is harmful or pointless for general health. Decisions about exercise for someone with dementia are best made with their care team.
Tus datos
For a person with dementia, simple measures such as daily steps or active minutes from a watch or phone, taken with a carer's help, can show whether routines are being kept. Use the same device and compare weekly trends. Fitness gains here should not be read as brain gains.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Objective
To estimate the effect of a moderate to high intensity aerobic and strength exercise training programme on cognitive impairment and other outcomes in people with mild to moderate dementia.
Design
Multicentre, pragmatic, investigator masked, randomised controlled trial.
Setting
National Health Service primary care, community and memory services, dementia research registers, and voluntary sector providers in 15 English regions.
Participants
494 people with dementia: 329 were assigned to an aerobic and strength exercise programme and 165 were assigned to usual care. Random allocation was 2:1 in favour of the exercise arm.
Interventions
Usual care plus four months of supervised exercise and support for ongoing physical activity, or usual care only. Interventions were delivered in community gym facilities and NHS premises.
Main outcome measures
The primary outcome was score on the Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog) at 12 months. Secondary outcomes included activities of daily living, neuropsychiatric symptoms, health related quality of life, and carer quality of life and burden. Physical fitness (including the six minute walk test) was measured in the exercise arm during the intervention.
Results
The average age of participants was 77 (SD 7.9) years and 301/494 (61%) were men. By 12 months the mean ADAS-cog score had increased to 25.2 (SD 12.3) in the exercise arm and 23.8 (SD 10.4) in the usual care arm (adjusted between group difference -1.4, 95% confidence interval -2.6 to -0.2, P=0.03). This indicates greater cognitive impairment in the exercise group, although the average difference is small and clinical relevance uncertain. No differences were found in secondary outcomes or preplanned subgroup analyses by dementia type (Alzheimer's disease or other), severity of cognitive impairment, sex, and mobility. Compliance with exercise was good. Over 65% of participants (214/329) attended more than three quarters of scheduled sessions. Six minute walking distance improved over six weeks (mean change 18.1 m, 95% confidence interval 11.6 m to 24.6 m).
Conclusion
A moderate to high intensity aerobic and strength exercise training programme does not slow cognitive impairment in people with mild to moderate dementia. The exercise training programme improved physical fitness, but there were no noticeable improvements in other clinical outcomes.
Trial registration
Current Controlled Trials ISRCTN10416500.
Fuentes y atribución
Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial.
Lamb SE, Sheehan B, Atherton N, Nichols V, Collins H, Mistry D, Dosanjh S, Slowther AM, Khan I, Petrou S, Lall R, DAPA Trial Investigators.
BMJ (Clinical research ed.) · 2018-05-16
DOI: 10.1136/bmj.k1675 ↗PubMed · 29769247 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

